Efficacy comparison of oral steroid, intratympanic... (2011 study) Skip to main content
Retrospective Study European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - 2011

Efficacy comparison of oral steroid, intratympanic steroid, hyperbaric oxygen and oral steroid + hyperbaric oxygen treatments in idiopathic sudden sensorineural hearing loss cases.

Alimoglu Y, Inci E, Edizer DT, Ozdilek A, Aslan M, European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - , 2011

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers in a clinic looked back at patient files from 2004 to 2010 and compared four treatments for sudden hearing loss of unknown cause: oral steroid, steroid placed in the middle ear, hyperbaric oxygen, and oral steroid plus hyperbaric oxygen.

What They Found

In this retrospective study of 217 patients (219 ears) with idiopathic sudden sensorineural hearing loss, the group that received oral steroid plus hyperbaric oxygen had the highest response rate, at 86.88% (53 of 61). The oral steroid group responded at 63.79% (37 of 58), the intratympanic steroid group at 46.51% (20 of 43), and the hyperbaric oxygen group at 43.85% (25 of 57). Complete recovery was also highest in the oral steroid plus hyperbaric oxygen group at 42.6% (26 of 61), compared with 19.0% for oral steroid, 17.5% for hyperbaric oxygen and 11.6% for intratympanic steroid. The combined group also had the highest mean hearing gain, with p less than 0.05 reported.

What This Means for Canadian Patients

For people with sudden hearing loss of unknown cause, this study found that patients who received oral steroid plus hyperbaric oxygen had a higher likelihood of recovery than patients who received any single treatment. Because the patients were not assigned to treatments at random, the results show an association in past records and do not prove that the combination caused the better outcomes. Anyone considering treatment should talk with their own hearing specialist.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The study looked back at existing patient files and did not assign patients to groups at random, so differences between the groups may reflect factors other than the treatment received, and the abstract does not give details of the oxygen treatment protocol.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Retrospective Study
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 21431435
Year Published 2011
Journal European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology -
MeSH Terms Administration, Oral; Administration, Topical; Audiometry; Follow-Up Studies; Glucocorticoids; Hearing; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Hyperbaric Oxygenation; Recovery of Function; Retrospective Studies; Treatment Outcome; Tympanic Membrane

Cite This Study

Share

This study relates to Sudden Sensorineural Hearing Loss. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology